Clinical Trial Detail

NCT ID NCT01503229
Title Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Washington
Indications

prostate adenocarcinoma

Therapies

Prednisone

Abiraterone

Age Groups: adult

No variant requirements are available.